[HTML] sciencedirect.com

[HTML][HTML] Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes

L Russo, L Muir, L Geletka, J Delproposto, N Baker… - Molecular …, 2020 - Elsevier
Objective Expansion of visceral adipose tissue (VAT) and metabolic inflammation are
consequences of obesity and associated with type 2 diabetes (T2DM). Metabolically …
被引用次数：51 相关文章

Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes

L Russo, L Muir, L Geletka… - Molecular …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective Expansion of visceral adipose tissue (VAT) and metabolic inflammation are
consequences of obesity and associated with type 2 diabetes (T2DM). Metabolically …
[HTML] nih.gov

[HTML][HTML] Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes

L Russo, L Muir, L Geletka, J Delproposto… - Molecular …, 2020 - ncbi.nlm.nih.gov
Objective Expansion of visceral adipose tissue (VAT) and metabolic inflammation are
consequences of obesity and associated with type 2 diabetes (T2DM). Metabolically …

Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes.

L Russo, L Muir, L Geletka, J Delproposto… - Molecular …, 2020 - europepmc.org
Objective Expansion of visceral adipose tissue (VAT) and metabolic inflammation are
consequences of obesity and associated with type 2 diabetes (T2DM). Metabolically …

Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes.

L Russo, L Muir, L Geletka, J Delproposto… - Molecular …, 2020 - europepmc.org
Objective Expansion of visceral adipose tissue (VAT) and metabolic inflammation are
consequences of obesity and associated with type 2 diabetes (T2DM). Metabolically …